Reference
Compare research compounds
Side-by-side reference for compounds that get studied together — chemistry, sequence, and what published work has examined for each. Figures come from the certificate for the lot currently in stock.
Research use only. Not for human or veterinary use. These pages describe what each compound is, not what it does for anyone.
Retatrutide vs Tirzepatide
Both are synthetic incretin-receptor agonists developed as single molecules that engage more than one receptor. The difference between them is how many receptors, and which.
BPC-157 vs TB-500
The two most-studied peptides in the tissue-repair literature. They are frequently mentioned together and are not structurally related; the mechanisms examined in published work are different.
Sermorelin vs CJC-1295 (no DAC) / Ipamorelin
Both are studied in relation to growth-hormone release, but they act on different receptors, and one of the two is a blend of two peptides rather than a single molecule.
Tesamorelin vs Sermorelin
Two GHRH analogues that differ in modification and in how far each has been characterised clinically.
Cagrilintide vs Tirzepatide
Both appear in metabolic-peptide research, and they are not the same class of molecule. One is an amylin analogue; the other is an incretin agonist.
MOTS-c vs NAD+
Both appear in mitochondrial research and they are entirely different kinds of molecule - one is a peptide encoded in mitochondrial DNA, the other a cellular cofactor.
KPV vs BPC-157
Both appear in inflammatory and tissue-repair research. One is a tripeptide fragment of a hormone; the other a synthetic sequence derived from a gastric protein.